Tenaya Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
TNYA Nasdaq 2830 www.tenayatherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Tenaya Therapeutics, Inc.

Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - May 15th, 2025 7:00 pm
Tenaya Therapeutics to Highlight Capsid Engineering, Gene Editing and Manufacturing Research at the ASGCT 28th Annual Meeting - May 13th, 2025 6:30 am
We're A Little Worried About Tenaya Therapeutics' (NASDAQ:TNYA) Cash Burn Rate - May 10th, 2025 6:17 am
Tenaya Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - May 7th, 2025 2:05 pm
Tenaya Therapeutics Presents Interim Data from RIDGE™ Natural History and Seroprevalence Study of Adults with PKP2-associated ARVC at Heart Rhythm 2025 - Apr 24th, 2025 12:07 pm
Tenaya highlights HCM gene therapy interim data at ACC 2025 - Apr 1st, 2025 10:26 am
Tenaya Therapeutics Announces Late Breaker Presentation of New Data from MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 at American College of Cardiology Annual Meeting - Mar 31st, 2025 8:00 am
Is Tenaya Therapeutics, Inc. (TNYA) the Cheapest Stock Insiders Are Buying In March? - Mar 28th, 2025 8:43 am
Tenaya Therapeutics, Inc. (TNYA): Among Stocks Receiving the Most Insider Love in March - Mar 25th, 2025 9:27 am
Tenaya Therapeutics publishes preclinical data on TN-201 in cardiac function - Mar 25th, 2025 6:45 am
Tenaya Therapeutics, Inc.'s (NASDAQ:TNYA) stock price dropped 13% last week; individual investors would not be happy - Mar 24th, 2025 6:52 am
Tenaya Therapeutics Publishes Preclinical Data Demonstrating TN-201 Enhances Cardiac Function and Survival in MYBPC3 Cardiomyopathy Models - Mar 24th, 2025 6:30 am
Tenaya Therapeutics Announces Late Breaker and New Data Presentations at the American College of Cardiology’s Annual Scientific Session - Mar 19th, 2025 6:30 am
Biotech Alert: Searches spiking for these stocks today - Mar 14th, 2025 10:15 am
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - Mar 10th, 2025 2:05 pm
Tenaya Therapeutics Announces Pricing of Public Offering - Mar 3rd, 2025 9:19 pm
Tenaya Therapeutics Announces Proposed Public Offering - Mar 3rd, 2025 2:10 pm
Tenaya Therapeutics to Participate in Upcoming March Investor Conferences - Mar 3rd, 2025 6:00 am
Tenaya Therapeutics Receives $8 Million Clinical Grant from California Institute for Regenerative Medicine - Feb 3rd, 2025 6:30 am
Tenaya Therapeutics Announces 2025 Strategic Priorities and Anticipated Milestones - Jan 13th, 2025 7:16 am